Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Cost of Revenue (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Cost of Revenue for 3 consecutive years, with $12.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue rose 29.41% year-over-year to $12.7 million, compared with a TTM value of $46.2 million through Sep 2025, down 20.01%, and an annual FY2024 reading of $49.4 million, down 12.22% over the prior year.
  • Cost of Revenue was $12.7 million for Q3 2025 at SBC Medical Group Holdings, down from $13.3 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $19.0 million in Q4 2023 and bottomed at $9.6 million in Q1 2025.
  • Average Cost of Revenue over 3 years is $13.0 million, with a median of $13.0 million recorded in 2025.
  • The sharpest move saw Cost of Revenue tumbled 44.43% in 2024, then grew 29.41% in 2025.
  • Year by year, Cost of Revenue stood at $19.0 million in 2023, then crashed by 44.43% to $10.5 million in 2024, then rose by 20.8% to $12.7 million in 2025.
  • Business Quant data shows Cost of Revenue for SBC at $12.7 million in Q3 2025, $13.3 million in Q2 2025, and $9.6 million in Q1 2025.